BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

NCT04891068 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Invasive
Early-stage Breast Cancer
High Risk Breast Carcinoma

Interventions

DRUG: Azacitidine

Sponsor

University of Illinois at Chicago